Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid
Dimopoulos, M.A., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., Migkou, M., Eleftherakis-Papaiakovou, E., Christoulas, D., Terpos, E., Bamias, A.
Published in Annals of oncology (01.01.2009)
Published in Annals of oncology (01.01.2009)
Get full text
Journal Article
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
Kastritis, E, Terpos, E, Moulopoulos, L, Spyropoulou-Vlachou, M, Kanellias, N, Eleftherakis-Papaiakovou, E, Gkotzamanidou, M, Migkou, M, Gavriatopoulou, M, Roussou, M, Tasidou, A, Dimopoulos, M A
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma
Dimopoulos, M A, Roussou, M, Gkotzamanidou, M, Nikitas, N, Psimenou, E, Mparmparoussi, D, Matsouka, C, Spyropoulou-Vlachou, M, Terpos, E, Kastritis, E
Published in Leukemia (01.02.2013)
Published in Leukemia (01.02.2013)
Get full text
Journal Article
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
KASTRITIS, E, ZERVAS, K, POULI, A, CHRISTOULAS, D, ROUSSOU, M, KARTASIS, Z, ECONOMOPOULOS, T, DIMOPOULOS, M. A, SYMEONIDIS, A, TERPOS, E, DELIMBASSI, S, ANAGNOSTOPOULOS, N, MICHALI, E, ZOMAS, A, KATODRITOU, E, GIKA, D
Published in Leukemia (01.06.2009)
Published in Leukemia (01.06.2009)
Get full text
Journal Article
Treatment of patients with relapsed refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies
DIMOPOULOS, M. A, KASTRITIS, E, EFSTATHIOU, E, TERPOS, E, CHRISTOULAS, D, MIGKOU, M, GAVRIATOPOULOU, M, GKOTZAMANIDOU, M, LAKOVAKI, M, MATSOUKA, C, MPARMPAROUSSI, D, ROUSSOU, M
Published in Leukemia (01.10.2010)
Published in Leukemia (01.10.2010)
Get full text
Journal Article
Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma
Kastritis, E, Zagouri, F, Symeonidis, A, Roussou, M, Sioni, A, Pouli, A, Delimpasi, S, Katodritou, E, Michalis, E, Michael, M, Hatzimichael, E, Vassou, A, Repousis, P, Christophoridou, A, Kartasis, Z, Stefanoudaki, E, Megalakaki, C, Giannouli, S, Kyrtsonis, M-C, Konstantopoulos, K, Spyroupoulou-Vlachou, M, Terpos, E, Dimopoulos, M A
Published in Leukemia (01.10.2014)
Published in Leukemia (01.10.2014)
Get full text
Journal Article
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis
TERPOS, E, KASTRITIS, E, ROUSSOU, M, HEATH, D, CHRISTOULAS, D, ANAGNOSTOPOULOS, N, ELEFTHERAKIS-PAPAIAKOVOU, E, TSIONOS, K, CROUCHER, P, DIMOPOULOS, M. A
Published in Leukemia (01.12.2008)
Published in Leukemia (01.12.2008)
Get full text
Journal Article
VTD consolidation, without bisphosphonates, reduces bone resorption and is associated with a very low incidence of skeletal-related events in myeloma patients post ASCT
Terpos, E, Christoulas, D, Kastritis, E, Roussou, M, Migkou, M, Eleutherakis-Papaiakovou, E, Gavriatopoulou, M, Gkotzamanidou, M, Kanellias, N, Manios, E, Papadimitriou, C, Dimopoulos, M A
Published in Leukemia (01.04.2014)
Published in Leukemia (01.04.2014)
Get full text
Journal Article
Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
Kastritis, E, Gavriatopoulou, M, Roussou, M, Fotiou, D, Ziogas, D C, Migkou, M, Eleutherakis-Papaiakovou, E, Panagiotidis, I, Kanellias, N, Psimenou, E, Papadopoulou, E, Pamboucas, C, Manios, E, Gakiopoulou, H, Ntalianis, A, Tasidou, A, Giannouli, S, Terpos, E, Dimopoulos, M A
Published in Blood cancer journal (New York) (16.06.2017)
Published in Blood cancer journal (New York) (16.06.2017)
Get full text
Journal Article
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents
MOULOPOULOS, L. A, DIMOPOULOS, M. A, GKOTZAMANIDOU, M, TASIDOU, A, TERPOS, E, CHRISTOULAS, D, KASTRITIS, E, ANAGNOSTOU, D, KOUREAS, A, ROUSSOU, M, GAVRIATOPOULOU, M, MIGKOU, M, IAKOVAKI, M
Published in Leukemia (01.06.2010)
Published in Leukemia (01.06.2010)
Get full text
Journal Article
Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit
Dimopoulos, M A, Roussou, M, Gavriatopoulou, M, Fotiou, D, Ziogas, D C, Migkou, M, Panagiotidis, I, Eleutherakis-Papaiakovou, E, Kanellias, N, Psimenou, E, Marinaki, S, Bacharaki, D, Mparmparoussi, D, Matsouka, C, Giannouli, S, Terpos, E, Kastritis, E
Published in Blood cancer journal (New York) (16.06.2017)
Published in Blood cancer journal (New York) (16.06.2017)
Get full text
Journal Article
P57 PRE‐EXPOSURE PROPHYLAXIS FOR COVID‐19 WITH TIXAGEVIMAB/CILGAVIMAB (EVUSHELD) IN PATIENTS WITH MULTIPLE MYELOMA
Ntanasis‐Stathopoulos, I., Gavriatopoulou, M., Eleutherakis‐Papaiakovou, E., Malandrakis, P., Spiliopoulou, V., Syrigou, R.E., Theodorakakou, F., Fotiou, D., Migkou, M., Roussou, M., Kastritis, E., Dimopoulos, M.A., Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
P54 ORAL ANTIVIRALS RITONAVIR‐NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID‐19; A SINGLE‐CENTER, PROSPECTIVE STUDY
Spiliopoulou, V., Ntanasis‐Stathopoulos, I., Malandrakis, P., Gavriatopoulou, M., Theodorakakou, F., Fotiou, D., Syrigou, R. E., Migkou, M., Roussou, M., Eleutherakis‐Papaiakovou, E., Kastritis, E., Dimopoulos, M. A, Terpos, E.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
Low circulating mannan-binding lectin levels correlate with increased frequency and severity of febrile episodes in myeloma patients who undergo ASCT and do not receive antibiotic prophylaxis
Eleutherakis-Papaiakovou, E, Dimopoulos, M-A, Kastritis, E, Christoulas, D, Roussou, M, Migkou, M, Gavriatopoulou, M, Fotiou, D, Panagiotidis, I, Ziogas, D C, Kanellias, N, Papadimitriou, C, Terpos, E
Published in Bone marrow transplantation (Basingstoke) (01.11.2017)
Published in Bone marrow transplantation (Basingstoke) (01.11.2017)
Get full text
Journal Article
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function
Dimopoulos, M.A., Kastritis, E., Michalis, E., Tsatalas, C., Michael, M., Pouli, A., Kartasis, Z., Delimpasi, S., Gika, D., Zomas, A., Roussou, M., Konstantopoulos, K., Parcharidou, A., Zervas, K., Terpos, E.
Published in Annals of oncology (01.03.2012)
Published in Annals of oncology (01.03.2012)
Get full text
Journal Article
Increased expression of macrophage inflammatory protein-1α on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma
Roussou, M, Tasidou, A, Dimopoulos, M.A, Kastritis, E, Migkou, M, Christoulas, D, Gavriatopoulou, M, Zagouri, F, Matsouka, C, Anagnostou, D, Terpos, E
Published in Leukemia (01.11.2009)
Published in Leukemia (01.11.2009)
Get full text
Journal Article
High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma
Terpos, E, Christoulas, D, Kastritis, E, Bagratuni, T, Gavriatopoulou, M, Roussou, M, Papatheodorou, A, Eleutherakis-Papaiakovou, E, Kanellias, N, Liakou, C, Panagiotidis, I, Migkou, M, Kokkoris, P, Moulopoulos, L A, Dimopoulos, M A
Published in Blood cancer journal (New York) (07.10.2016)
Published in Blood cancer journal (New York) (07.10.2016)
Get full text
Journal Article
Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study
Terpos, E., Symeonidis, A., Delimpasi, S., Zamagni, E., Katodritou, E., Rivolti, E., Kyrtsonis, M., Fotiou, D., Kanellias, N., Migkou, M., Roussou, M., Gavriatopoulou, M., Hatjiharissi, E., Cavo, M., Dimopoulos, M.
Published in Hematology, Transfusion and Cell Therapy (01.10.2020)
Published in Hematology, Transfusion and Cell Therapy (01.10.2020)
Get full text
Journal Article
Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging
Kastritis, E, Gavriatopoulou, M, Dimopoulos, M A, Eleutherakis-Papaiakovou, E, Kanellias, N, Roussou, M, Pamboucas, C, Toumanidis, S T, Terpos, E
Published in Blood cancer journal (New York) (05.06.2015)
Published in Blood cancer journal (New York) (05.06.2015)
Get full text
Journal Article
Osteoprotegerin is a Significant Prognostic Factor for Overall Survival in Patients with Primary Systemic Amyloidosis Independent of the Mayo Staging
Kastritis, E, Gavriatopoulos, M, Dimopoulos, M.A, Eleutherakis-Papaiakovou, E, Kanellias, N, Roussou, M, Pamboucas, C, Toumanidis, S.Th, Terpos, E
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article